Reviews and feature articlesAnaphylaxis: Lessons from mouse models
Section snippets
Two pathways of murine systemic anaphylaxis
Central to all studies of anaphylaxis in the mouse is the observation that systemic anaphylaxis (rapid and potentially reversible hypotension, hypothermia, decreased mobility, and scratching) can be mediated by 2 independent mechanisms.3 One, which I refer to as the classic pathway, involves mast cells sensitized by IgE antibodies bound to FcɛRI. Antigen-induced cross-linking of mast cell–associated IgE leads rapidly to mast cell degranulation with release of mediators and enzymes, such as the
Physiologic and pharmacologic modulators of systemic anaphylaxis
The most direct determinants of anaphylaxis induction and severity are the extent and rapidity of cross-linking of mast cell FcɛRI and macrophage FcγRIII. These are influenced by antigen dose, speed of antigen access to the circulation (ie, route of antigen administration), concentration of IgE and IgG antibody, antibody affinity, number and activation state of mast cells and macrophages, and density of mast cell FcɛRI and macrophage FcγRIII. Multiple additional factors, however, can act at
Mouse models of intestinal anaphylaxis
Allergen ingestion can induce the shock syndrome characterized as systemic anaphylaxis but more commonly induces gastrointestinal symptoms, such as diarrhea.1, 46, 47 Three experimental mouse models of intestinal anaphylaxis have been described: one in which mice are sensitized by ingestion of an allergen, such as peanut extract, with cholera toxin48; one in which mice are sensitized by means of intraperitoneal injection of chicken ovalbumin (OVA) with the adjuvant alum (aluminum hydroxide)49;
Passive cutaneous anaphylaxis
Although passive cutaneous anaphylaxis (PCA) is more useful as a model for probing mechanisms of anaphylaxis than a model of human allergy, it has played an historically important role in dissection of the mechanisms of anaphylaxis.57 Unlike systemic anaphylaxis in the mouse, PCA mediated by autologous antibody appears to be entirely mast cell dependent and is primarily dependent on IgE.58 PCA can also be mediated, however, by a fraction of IgG1 molecules, called anaphylactic IgG1. These IgG1
Relevance of mouse models to human anaphylaxis
The focus of this article on specifics of mouse models of anaphylaxis, including the effects of specific mouse IgG isotypes and immunoglobulin receptors, raises questions about the human relevance of these studies. The many similarities and few differences between the mouse and human immune systems that are germane to the relevance of mouse models to human anaphylaxis have been previously summarized (reproduced here as Table II).61 There are no precise homologies between mouse and human IgG
Implications for prophylaxis and treatment
Regardless of the importance of IgG-mediated anaphylaxis in human subjects, studies with mouse models have suggested several approaches that might be useful for anaphylaxis prophylaxis (Table III) but few or none that might be useful for treatment. The possible prophylactic closest to the clinic is an anti-IgE mAb that binds to an IgE epitope blocked by FcɛRI, so that it can prevent IgE binding to mast cell FcɛRI but cannot induce anaphylaxis by cross-linking IgE already bound to FcɛRI on mast
Future goals of rodent studies in anaphylaxis
Many goals for future research in this area are obvious continuations of present studies, including (1) determination of the requirements for IL-4 and IL-13 in maintaining allergen sensitization once it has been induced, (2) identification of the ligands of each mast cell– and macrophage-associated ITIM-containing receptor, (3) evaluation of the relative importance of the classic and alternative pathways of anaphylaxis in response to different allergens, (4) identification of better footprints
References (85)
Anaphylaxis in the general population: a frequent and occasionally fatal disorder that is underrecognized
J Allergy Clin Immunol
(1999)- et al.
Pathways of anaphylaxis in the mouse
J Allergy Clin Immunol
(2002) - et al.
Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the beta-chymase, mouse mast cell protease-1
Am J Pathol
(1998) - et al.
Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice
Immunity
(1996) - et al.
FcR γ chain deletion results in pleiotrophic effector cell defects
Cell
(1994) - et al.
Fer and Fps/Fes participate in a Lyn-dependent pathway from FcɛRI to platelet-endothelial cell adhesion molecule 1 to limit mast cell activation
J Biol Chem
(2006) - et al.
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
Cell
(1995) - et al.
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
Immunity
(1996) - et al.
A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses
J Allergy Clin Immunol
(2000) - et al.
Molecular mechanisms of anaphylaxis: lessons from studies with murine models
J Allergy Clin Immunol
(2005)
The incidence and management of infusion reactions to infliximab: a large center experience
Am J Gastroenterol
Characterization of an anaphylactoid reaction to omalizumab
Ann Allergy Asthma Immunol
Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis
Pharmacol Res Commun
Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity
Clin Immunol
Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization
J Allergy Clin Immunol
Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcɛ bifunctional fusion protein
J Allergy Clin Immunol
Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a
J Allergy Clin Immunol
Egg oral immunotherapy in nonanaphylactic children with egg allergy
J Allergy Clin Immunol
Oral peanut immunotherapy for peanut allergic patients
J Allergy Clin Immunol
Risk assessment in anaphylaxis: current and future approaches
J Allergy Clin Immunol
IgG Blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb crosslinking
J Clin Invest
Binding characteristics of human IgE receptors and initial triggering events in human mast cells for histamine release
Monogr Allergy
Inhibition of anaphylactic shock by gadolinium chloride-induced Kupffer cell blockade
Agents Actions
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function)
Agents Actions
Murine IgG1 complexes trigger immune effector functions predominantly via FcγRIII (CD16)
J Immunol
A lethal role of platelet activating factor in anaphylactic shock in mice
J Pharmacol Exp Ther
Active anaphylaxis in IgE-deficient mice
Nature
Augmented humoral and anaphylactic responses in FcγRII-deficient mice
Nature
Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1- dependent passive anaphylaxis
J Clin Invest
IgG Fc receptors
Annu Rev Immunol
Immune response potential of mast cell-deficient W/Wv mice
Int Arch Allergy Appl Immunol
Absence of FcɛRI α chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcɛRI and FcγRIII for limiting amounts of FcR β and γ chains
J Clin Invest
Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice
J Immunol
Platelet-activating factor and shock
Prog Biochem Pharmacol
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
J Immunol
The high-affinity IgE receptor (FcɛRI): from physiology to pathology
Annu Rev Immunol
Divergent Immunoglobulin G subclass activity through selective Fc receptor binding
Science
Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice
J Exp Med
Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23
J Clin Invest
Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG
J Exp Med
The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells
J Immunol
Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor γ chain
J Exp Med
Cited by (384)
Comparison of cow's milk allergy models highlighted higher humoral and Th2 immune responses in BALB/c than C3H/HeNCrl mice
2024, Food and Chemical ToxicologyMast cell–sensory neuron crosstalk in allergic diseases
2024, Journal of Allergy and Clinical ImmunologyChanges of allergic inflammation and immunological parameters after Alt a 1 and A. alternata immunotherapy in mice
2023, World Allergy Organization JournalClinacanthus nutans aqueous leaves extract exerts anti-allergic activity in preclinical anaphylactic models via alternative IgG pathway
2023, Journal of Ethnopharmacology
(Supported by an unrestricted educational grant from Genentech, Inc. and Novartis Pharmaceuticals Corporation)
Series editors: Joshua A. Boyce, MD, Fred Finkelman, MD, William T. Shearer, MD, PhD, and Donata Vercelli, MD
Supported by grants R01 AI35987, R01 AI45766, R01 AI052099, and P01 HL076383; a Veterans Administration Merit Award; and the Food Allergy and Anaphylaxis Network.
Disclosure of potential conflict of interest: F. D. Finkelman has consulting arrangements with Abbott, Plexxikon, Peptimmune, CSI, Amgen, and Wyeth; has patent licensing arrangements with BD PharMingen and eBioscience; and has received grant support from Abbott and Plexxikon.